Literature DB >> 26611754

Nurse-Led Programs to Facilitate Enrollment to Children's Oncology Group Cancer Control Trials.

Maureen Haugen1, Katherine Patterson Kelly2, Marcia Leonard3, Denise Mills4, Lillian Sung4, Catriona Mowbray5, Wendy Landier6.   

Abstract

The progress made over the past 50 years in disease-directed clinical trials has significantly increased cure rates for children and adolescents with cancer. The Children's Oncology Group (COG) is now conducting more studies that emphasize improving quality of life for young people with cancer. These types of clinical trials are classified as cancer control (CCL) studies by the National Cancer Institute and require different resources and approaches to facilitate adequate accrual and implementation at COG institutions. Several COG institutions that had previously experienced problems with low accruals to CCL trials have successfully implemented local nursing leadership for these types of studies. Successful models of nurses as institutional leaders and "champions" of CCL trials are described.
© 2015 by Association of Pediatric Hematology/Oncology Nurses.

Entities:  

Keywords:  cancer control clinical trials; nurses as leaders; pediatric oncology

Mesh:

Year:  2015        PMID: 26611754      PMCID: PMC5013656          DOI: 10.1177/1043454215617458

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  13 in total

1.  The evolution of cancer control research: an international perspective from Canada and the United States.

Authors:  Allan Best; Robert A Hiatt; Roy Cameron; Barbara K Rimer; David B Abrams
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-08       Impact factor: 4.254

2.  Accrual to clinical trials: let's look at the physicians.

Authors:  Lori M Minasian; Ann M O'Mara
Journal:  J Natl Cancer Inst       Date:  2011-02-11       Impact factor: 13.506

3.  Childhood and adolescent cancer statistics, 2014.

Authors:  Elizabeth Ward; Carol DeSantis; Anthony Robbins; Betsy Kohler; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-31       Impact factor: 508.702

4.  Childhood cancer: patterns of protocol participation in a national survey.

Authors:  S J Shochat; A M Fremgen; S B Murphy; C Hutchison; S S Donaldson; G M Haase; A J Provisor; R E Clive-Bumpus; D P Winchester
Journal:  CA Cancer J Clin       Date:  2001 Mar-Apr       Impact factor: 508.702

5.  The Children's Oncology Group's 2013 five year blueprint for research.

Authors:  Peter C Adamson
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 6.  Children's Oncology Group's 2013 blueprint for research: nursing discipline.

Authors:  Wendy Landier; Marcia Leonard; Kathleen S Ruccione
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 7.  Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes.

Authors:  Saro H Armenian; Wendy Landier; Melissa M Hudson; Leslie L Robison; Smita Bhatia
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 8.  Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care.

Authors:  Lillian Sung; Theo Zaoutis; Nicole J Ullrich; Donna Johnston; Lee Dupuis; Elena Ladas
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 9.  Children's Oncology Group's 2013 blueprint for research: behavioral science.

Authors:  Robert B Noll; Sunita K Patel; Leanne Embry; Kristina K Hardy; Wendy Pelletier; Robert D Annett; Andrea Patenaude; E Anne Lown; Stephen A Sands; Lamia P Barakat
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

10.  Reasons for non-completion of health related quality of life evaluations in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Authors:  Donna L Johnston; Rajaram Nagarajan; Mae Caparas; Fiona Schulte; Patricia Cullen; Richard Aplenc; Lillian Sung
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

View more
  4 in total

1.  The Role of Oncology Nurses in Discussing Clinical Trials.

Authors:  Susan A Flocke; Elizabeth Antognoli; Barbara J Daly; Brigid Jackson; Sarah E Fulton; Tasnuva M Liu; Jessica Surdam; Sharon Manne; Neal J Meropol
Journal:  Oncol Nurs Forum       Date:  2017-09-01       Impact factor: 2.172

2.  Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials.

Authors:  Taylor Bucy; John M Zoscak; Motomi Mori; Uma Borate
Journal:  Blood Adv       Date:  2019-12-10

3.  A National Study of Oncology Nurses Discussing Cancer Clinical Trials With Patients.

Authors:  Susan A Flocke; Nora L Nock; Sarah Fulton; Seunghee Margevicius; Sharon Manne; Neal J Meropol; Barbara J Daly
Journal:  West J Nurs Res       Date:  2019-02-19       Impact factor: 1.967

4.  Oncologic patients' misconceptions may impede enrollment into clinical trials: a cross-sectional study.

Authors:  Nethanel Asher; Ari Raphael; Ido Wolf; Sharon Pelles; Ravit Geva
Journal:  BMC Med Res Methodol       Date:  2022-01-07       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.